1-(4-Nitro-phenyl)-3-(2,2,4,4-tetramethyl-thiochroman-6-yl)-thiourea

ID: ALA7075

Cas Number: 361483-66-1

PubChem CID: 9844020

Max Phase: Phase

Molecular Formula: C20H23N3O2S2

Molecular Weight: 401.56

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Synonyms: Sheta-2 | Sheta2 | NSC-721689 | NSC-726189 | SHETA-2 | SHETA2 | SHetA2|Sheta-2|NSC-726189|NSC-721689|S886C92NJ7|361483-66-1|CHEMBL7075|UNII-S886C92NJ7|N-(3,4-Dihydro-2,2,4,4-tetramethyl-2H-1-benzothiopyran-6-yl)-N'-(4-nitrophenyl)thiourea|Thiourea, N-(3,4-dihydro-2,2,4,4-tetramethyl-2H-1-benzothiopyran-6-yl)-N'-(4-nitrophenyl)-|1-(4-nitrophenyl)-3-(2,2,4,4-tetramethylthiochroman-6-yl)thiourea|SCHEMBL13417328|BDBM50539102|NSC726189|1-(4-nitrophenyl)-3-(2,2,4,4-tetramethyl-3H-thiochromen-6-yl)thioShow More

Canonical SMILES:  CC1(C)CC(C)(C)c2cc(NC(=S)Nc3ccc([N+](=O)[O-])cc3)ccc2S1

Standard InChI:  InChI=1S/C20H23N3O2S2/c1-19(2)12-20(3,4)27-17-10-7-14(11-16(17)19)22-18(26)21-13-5-8-15(9-6-13)23(24)25/h5-11H,12H2,1-4H3,(H2,21,22,26)

Standard InChI Key:  FWWKIYPMUZVMQG-UHFFFAOYSA-N

Molfile:  

Thiourea, N-(3,4-dihydro-2,2,4,4-tetramethyl-2H-1-benzothiopyran-6-yl)-N'-(4-...
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   29.4766  -11.8036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4793  -10.6084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4821  -11.8036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1283   -9.8284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1283   -8.2684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4793   -7.4884    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   31.8304   -8.2684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8304   -9.8284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3666   -8.5393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3639   -6.8025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7774   -7.4884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4263   -8.2684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4263   -9.8284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7774  -10.6084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0753  -10.6085    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.7244   -9.8284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7244   -8.2684    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.3733   -7.4885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3733   -5.9284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0224   -5.1484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6713   -5.9285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6713   -7.4885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0224   -8.2684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3203   -5.1484    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.3203   -3.5884    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.9694   -5.9285    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.3733  -10.6085    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  7  6  1  0
  8  7  1  0
  2  8  1  0
  7  9  1  0
  7 10  1  0
  5 11  2  0
 11 12  1  0
 13 12  2  0
 14 13  1  0
  4 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 22 21  1  0
 23 22  2  0
 18 23  1  0
 21 24  1  0
 24 25  1  0
 24 26  2  0
 16 27  2  0
M  CHG  2  24   1  25  -1
M  END

Alternative Forms

  1. Parent:

    ALA7075

    SHETA-2

Associated Targets(Human)

Caov-3 cell line (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-OV-3 (52876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-453 (1139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNCaP (8286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HSPA9 Tchem Stress-70 protein, mitochondrial (43 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (6361 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: YesAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 401.56Molecular Weight (Monoisotopic): 401.1232AlogP: 5.96#Rotatable Bonds: 3
Polar Surface Area: 67.20Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.63CX Basic pKa: CX LogP: 6.03CX LogD: 6.03
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.38Np Likeness Score: -1.19

References

1. Liu S, Brown CW, Berlin KD, Dhar A, Guruswamy S, Brown D, Gardner GJ, Birrer MJ, Benbrook DM..  (2004)  Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.,  47  (4): [PMID:14761202] [10.1021/jm030346v]
2. Liu S, Louie MC, Rajagopalan V, Zhou G, Ponce E, Nguyen T, Green L..  (2015)  Synthesis and evaluation of the diarylthiourea analogs as novel anti-cancer agents.,  25  (6): [PMID:25701251] [10.1016/j.bmcl.2015.01.042]
3. Gnanasekaran KK, Benbrook DM, Nammalwar B, Thavathiru E, Bunce RA, Berlin KD..  (2015)  Synthesis and evaluation of second generation Flex-Het scaffolds against the human ovarian cancer A2780 cell line.,  96  [PMID:25880346] [10.1016/j.ejmech.2015.03.070]
4. Watts FM, Pouland T, Bunce RA, Berlin KD, Benbrook DM, Mashayekhi M, Bhandari D, Zhou D..  (2018)  Activity of oxygen-versus sulfur-containing analogs of the Flex-Het anticancer agent SHetA2.,  158  [PMID:30245396] [10.1016/j.ejmech.2018.09.036]
5. Nammalwar B, Bunce RA, Berlin KD, Benbrook DM, Toal C..  (2019)  Synthesis and biological evaluation of SHetA2 (NSC-721689) analogs against the ovarian cancer cell line A2780.,  170  [PMID:30878829] [10.1016/j.ejmech.2019.03.010]
6. Gnanasekaran KK, Pouland T, Bunce RA, Darrell Berlin K, Abuskhuna S, Bhandari D, Mashayekhi M, Zhou DH, Benbrook DM..  (2020)  Tetrahydroquinoline units in flexible heteroarotinoids (Flex-Hets) convey anti-cancer properties in A2780 ovarian cancer cells.,  28  (1): [PMID:31831296] [10.1016/j.bmc.2019.115244]
7. Unpublished dataset,